Yonsei University

We track 2 ClinicalTrials.gov studies led by Yonsei University. The portfolio skews toward Phase 2 (1 trials).

2 clinical trials sponsored by Yonsei University.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
N/A 1
50%

Trial Status Breakdown

Trials by Yonsei University

Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients With EGFR-mutant, Locally Advanced or Metastatic/Recurrent Non-Small Cell Lung Cancer (INSTAR Study)

NCT07507188 · NOT YET RECRUITING · Phase 2

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

NCT07515859 · COMPLETED · N/A

Frequently Asked Questions

How many clinical trials does Yonsei University sponsor?

Yonsei University currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2, N/A.

What conditions does Yonsei University research?

Yonsei University conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Yonsei University recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More